Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies

BJU International

Volumn 114, Issue 4, 2014, Pages 541-548

  Javed, Saqib ^a   Chadwick, Eliot ^a   Edwards, Albert A ^a   Beveridge, Sabeena ^a   Laing, Robert ^a   Bott, Simon ^b   Eden, Christopher ^a   Langley, Stephen ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b FRIMLEY PARK HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

histoscanning; prostate cancer; transperineal prostate biopsy; transrectal prostate biopsy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPH; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MECHANICAL PROBE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; TRANSPERINEAL TEMPLATE PROSTATE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; TRANSRECTAL ULTRASONOGRAPHY GUIDED BIOPSY; TUMOR VOLUME; ADENOCARCINOMA; BLOOD; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROSTATIC NEOPLASMS;

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN;

EID: 84908134686     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12568     Document Type: Article

References (20)

1. Ferlay J, Parkin DM, Steliarova-Foucher E,. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-781
2. Djavan B, Mazal P, Zlotta A, et al. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate 2001; 47: 111-117
3. Bott SR, Henderson A, McLarty E, Langley SE,. A brachytherapy template approach to standardize saturation prostatic biopsy. BJU Int 2004; 93: 629-630
4. National Institute for Health and Care Excellence. Transperineal Template Biopsy of the Prostate. IPG364. London: National Institute for Health and Care Excellence, 2010
5. Bott SR, Young MP, Kellett MJ, Parkinson MC,. Contributors to the UCL Hospitals' Trust Radical Prostatectomy Database. Anterior prostate cancer: is it more difficult to diagnose? BJU Int 2002; 89: 886-889
6. Bott SR, Henderson A, Halls JE, Montgomery BS, Laing R, Langley SE,. Extensive transperineal template biopsies of prostate: modified technique and results. Urology 2006; 68: 1037-1041
7. Ayres BE, Montgomery BS, Barber NJ, et al. The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance. BJU Int 2012; 109: 1170-1176
8. Braeckman J, Autier P, Soviany C, et al. The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 2008; 102: 1560-1565
9. Braeckman J, Autier P, Garbar C, et al. Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int 2008; 101: 293-298
10. Simmons LA, Autier P, Zát'ura F, et al. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning™. BJU Int 2012; 110: 28-35
11. Javed S, Chadwick E, Beveridge S, Bott S, Eden C, Langley S,. Does Prostate HistoScanningTM accurately identify prostate cancer, measure tumour volume and assess pathological stage prior to radical prostatectomy? J Clin Urol 2013; 6: 395-402. Available at: http://uro.sagepub.com/content/6/6/395. Accessed December 2013
12. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Radiol 2003; 58: 575-580
13. Ahmed HU, Hindley RG, Dickinson L, et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol 2012; 13: 622-632
14. Mitterberger M, Aigner F, Pinggera GM, et al. Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy. BJU Int 2010; 106: 1315-1318
15. Pallwein L, Mitterberger M, Pinggera G, et al. Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients. Eur J Radiol 2008; 65: 304-310
16. Salomon G, Köllerman J, Thederan I, et al. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol 2008; 54: 1354-1362
17. Kirkham AP, Emberton M, Allen C,. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 2006; 50: 1163-1174
18. Puech P, Potiron E, Lemaitre L, et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology 2009; 74: 1094-1099
19. Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L,. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006; 176 (6 Pt 1): 2432-2437
20. Kasivisvanathan V, Dufour R, Moore CM, et al. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 2013; 189: 860-866